GENOMIC HEALTH INC | 29,072 Euro | +0,502 +1,76 % | |
| WKN: A0F6J5 ISIN: US37244C1018 Ticker-Symbol: G7H | Frankfurt | 22.05.13 | 11:14 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ Biotech |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 21.05. | Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting | 16 | PR Newswire | |
| REDWOOD CITY, Calif., May 21, 2013 /PRNewswire/ --Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from ten studies in breast, colon and prostate cancer, including a large... Mehr lesen zu: Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting | ||||
| 20.05. | Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Genomic Health Is Up 22.6% | - | SmarTrend | |
| 18.05. | U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying | 6 | Benzinga.com | |
| 16.05. | The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals | 104 | PR Newswire | |
| CHICAGO, May 16, 2013 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events... Mehr lesen zu: The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals | ||||
| 16.05. | Genomic Health's New Prostate Test May Extend The Stock's Upward Climb | - | Seeking Alpha | |
| 15.05. | An Insider Sells Major Stake of General Growth Properties While Directors at Genomic Health and US Steel Buy Stock | 3 | Minyanville | |
| 10.05. | Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test | 1 | Benzinga.com | |
| 10.05. | Genomic Health (GHDX) Oncotype DX Coverage Expanded for Medicare Patients | - | StreetInsider.com | |
| 10.05. | Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis | 62 | PR Newswire | |
| REDWOOD CITY, Calif., May 10, 2013 /PRNewswire/ --Genomic Health, Inc. (Nasdaq: GHDX) today announced that, effective May 8, 2013, Palmetto GBA, the designated national contractor for... Mehr lesen zu: Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis | ||||
| 09.05. | Genomic Health Inc. - Special Call | 2 | Seeking Alpha | |
| 08.05. | Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test | - | Benzinga.com | |
| 08.05. | Genomic Health targets better prostate cancer treatment with new test | 1 | bizjournals | |
| 08.05. | Genomic Health Announces Availability of Oncotype DX Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments | 86 | PR Newswire | |
| SAN DIEGO, May 8, 2013 /PRNewswire/ --Genomic Health, Inc. (Nasdaq: GHDX) is making its Oncotype DX® prostate cancer test available to physicians and their patients today following the presentation... Mehr lesen zu: Genomic Health Announces Availability of Oncotype DX Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments | ||||
| 07.05. | Genomic Health to Present at Bank of America Merrill Lynch Health Care Conference | 43 | PR Newswire | |
| REDWOOD CITY, Calif., May 7, 2013 /PRNewswire/ --Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the 2013 Bank of America Merrill Lynch Health... Mehr lesen zu: Genomic Health to Present at Bank of America Merrill Lynch Health Care Conference | ||||
| 03.05. | Why Genomic Health Shares Popped | 2 | Motley Fool | |
| 03.05. | Genomic Health Management Discusses Q1 2013 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 02.05. | Genomic Health and ECOG-ACRIN Cancer Research Group Announce Publication of Positive DCIS Validation Study in the Journal of the National Cancer Institute | 35 | PR Newswire | |
| REDWOOD CITY, Calif. and PHILADELPHIA, May 2, 2013 /PRNewswire/ --Genomic Health, Inc. (Nasdaq: GHDX) and the ECOG-ACRIN Cancer Research Group announced today that the Journal of the National Cancer... Mehr lesen zu: Genomic Health and ECOG-ACRIN Cancer Research Group Announce Publication of Positive DCIS Validation Study in the Journal of the National Cancer Institute | ||||
| 02.05. | Genomic Health Announces First Quarter 2013 Financial Results and Business Progress | 15 | PR Newswire | |
| REDWOOD CITY, Calif., May 2, 2013 /PRNewswire/ --Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2013.
(Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO)... Mehr lesen zu: Genomic Health Announces First Quarter 2013 Financial Results and Business Progress | ||||
| 01.05. | Genomic Health Announces Investor Webcast and Conference Call to Review Positive Clinical Validation and Development of the Oncotype DX Prostate Cancer Test on Wednesday, May 8, 2013 | 34 | PR Newswire | |
| REDWOOD CITY,Calif., May 1, 2013 /PRNewswire/ --Genomic Health, Inc.(Nasdaq: GHDX) today announced that it will host an investor webcast and conference call to discuss... Mehr lesen zu: Genomic Health Announces Investor Webcast and Conference Call to Review Positive Clinical Validation and Development of the Oncotype DX Prostate Cancer Test on Wednesday, May 8, 2013 | ||||
| 25.04. | Genomic Health to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 2, 2013 | 21 | PR Newswire | |
| REDWOOD CITY, Calif., April 25, 2013 /PRNewswire/ -- Genomic Health, Inc.(Nasdaq: GHDX) today announced that the company will host a conference call and webcast onThursday, May 2 at4:30 p.m. Eastern... Mehr lesen zu: Genomic Health to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 2, 2013 | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MORPHOSYS | 35,305 | -1,44 % | MorphoSys AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| AMGEN | 82,78 | +3,51 % | Amgen Announces Voting Results of Annual Meeting of Stockholders |
| BIOGEN IDEC | 181,67 | +0,93 % | Biogen Idec Submits BLA To FDA For Approval Of Plegridy In Multiple Sclerosis |
| QIAGEN | 14,665 | +1,03 % | Qiagen und SYGNIS Pharma schließen Lizenzvertrag |
| SHIRE | 25,331 | +5,52 % | SHIRE PLC - Transaction in Own Shares |
